SCHEMBL30654713

SCHEMBL30654713

CCCCCCCCCCCCC/C=C/[C@@H](O)[C@H](C)NC(=O)CCCCCCCCCCCCCCCCCCCCCCC

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ ASAH2 Q9NR71 2/20 1.00
▸ CETP P11597 4/20 0.71
▸ THRB P10828 1/20 0.71
▸ MEN1 O00255 1/20 0.71
▸ KMT2A Q03164 1/20 0.71
▸ TP53 P04637 2/20 0.67
▸ ALDH1A1 P00352 1/20 0.67
▸ PLA2G4A P47712 4/20 0.60
▸ FAAH O00519 2/20 0.58
▸ CYP1A2 P05177 1/20 0.55
▸ CYP2D6 P10635 1/20 0.55
▸ MAPT P10636 1/20 0.55
▸ CYP2C9 P11712 1/20 0.55
▸ MAPK1 P28482 1/20 0.55
▸ CYP2C19 P33261 1/20 0.55
▸ ASAH1 Q13510 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18506537 1.00 ASAH2 (1.00) ASAH2CETPTHRBMEN1KMT2A
SCHEMBL30145483 1.00 ASAH2 (1.00) ASAH2CETPTHRBMEN1KMT2A
SCHEMBL13849917 1.00 ASAH2 (1.00) ASAH2CETPTHRBMEN1KMT2A
SCHEMBL27013983 1.00 ASAH2 (1.00) ASAH2CETPTHRBMEN1KMT2A
SCHEMBL12252107 0.99 ASAH2 (0.97) ASAH2CETPTHRBMEN1KMT2A
SCHEMBL29967428 0.99 ASAH2 (0.97) ASAH2CETPTHRBMEN1KMT2A
SCHEMBL12227954 0.99 ASAH2 (0.97) ASAH2CETPTHRBMEN1KMT2A
Sulfuric Acid SCHEMBL10522463 0.93 ASAH2 (0.87) ASAH2CETPTHRBMEN1KMT2A
SCHEMBL18506534 0.86 ASAH2 (0.75) ASAH2CETPTHRBMEN1KMT2A
SCHEMBL3712347 0.85 ASAH2 (0.74) ASAH2CETPTHRBMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4522646-A2 APOE LIPOPROTEIN SYSTEMS Kisbee Therapeutics, Inc. (US) 2025-03-19 — — EP disclosed
WO-2023220387-A2 APOE LIPOPROTEIN SYSTEMS KISBEE THERAPEUTICS, INC. (US) 2023-11-16 — — WO disclosed
Send feedback